DarioHealth (NASDAQ:DRIO) is scheduled to be releasing its earnings data before the market opens on Tuesday, March 20th. Analysts expect DarioHealth to post earnings of ($0.28) per share for the quarter.
DarioHealth (NASDAQ:DRIO) opened at $1.56 on Tuesday. DarioHealth has a 12-month low of $1.32 and a 12-month high of $4.70. The firm has a market capitalization of $16.05, a PE ratio of -1.26 and a beta of -1.68.
A number of research firms have recently weighed in on DRIO. ValuEngine raised DarioHealth from a “strong sell” rating to a “sell” rating in a research report on Friday, February 2nd. Aegis reaffirmed a “buy” rating on shares of DarioHealth in a research report on Friday, December 8th.
DarioHealth Company Profile
DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company’s product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter.
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.